# Study of the Crystallization Inhibition Capacity of the Uric Acid in Urine in a Group of Lithiasic Patients After Intake of a Food Supplement

> **NCT03483532** · — · COMPLETED · sponsor: **Devicare S.L.** · enrollment: 54 (actual)

## Conditions studied

- Lithiasis

## Interventions

- **DIETARY_SUPPLEMENT:** Lit Control pH Up
- **DIETARY_SUPPLEMENT:** dry cocoa extract

## Key facts

- **NCT ID:** NCT03483532
- **Lead sponsor:** Devicare S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-06
- **Primary completion:** 2019-12-02
- **Final completion:** 2019-12-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483532, "Study of the Crystallization Inhibition Capacity of the Uric Acid in Urine in a Group of Lithiasic Patients After Intake of a Food Supplement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03483532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*